Applications of microarrays and biochips in pharmacogenomics

Methods in Molecular Biology

Volumn 448, Issue , 2008, Pages 21-30

  Hardiman, Gary ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

AmpliChip; Biochips; Microarrays; P450; Pharmacogenetics

Indexed keywords

EID: 84934439704     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-205-2_2     Document Type: Article

References (27)

1. Marton, M. J., DeRisi, J. L., Bennett, H. A., et al. (1998) Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4, 1293-1301.
2. Vilo, J., and Kivinen, K. (2001) Regulatory sequence analysis: application to the interpretation of gene expression. Eur. Neuropsychopharmacol. 11, 399-411.
3. Hardiman, G. Microarrays technologies 2006: an overview (2006). Pharmacogenomics. 8, 1153-1158.
4. Waring, J.F., Ciurlionis, R., Jolly, R.A., Heindel, M., and Ulrich, R.G. (2001) Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120, 359-368.
5. Hamadeh, H.K., Amin, R.P., Paules, R.S., and Afshari, C.A. (2002) An overview of toxicogenomics. Curr. Issues Mol. Biol. 4, 45-56.
6. Johnson, J.A. (2001) Drug target pharmacogenomics: an overview. Am. J. Pharmacogenomics. 1, 271-281.
7. Kruglyak, L., and Nickerson, D.A. (2001) Variation is the spice of life. Nat. Genet. 27, 234-236.
8. Ensom, M.H., Chang, T.K., and Patel, P. (2001) Pharmacogenetics: the therapeutic drug monitoring of the future? Clin. Pharmacokinet. 40, 783-802.
9. Routledge, P.A., O'Mahony, M.S., and Woodhouse, K.W. (2004). Adverse drug reactions in elderly patients. Br. J. Clin. Pharmacol. 57, 121-126.
10. Lundkvist, J., and Jönsson, B. (2004) Pharmacoeconomics of adverse drug reactions. Fund. Clin. Pharmacol. 18, 275-280.
11. Obayashi, K., Nakamura, K., Kawana, J., et al. (2006) VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients. Clin. Pharmacol. Ther. 80, 169-178.
12. Eichelbaum, M., Ingelman-Sundberg, M., and Evans, W.E. (2006) Pharmacogenomics and individualized drug therapy. Annu. Rev. Med. 57, 119-137.
13. Desta, Z., Zhao, X., Shin, J.G., and Flockhart, D.A. (2002) Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin. Pharmacokinet. 41, 913-958.
14. de Leon, J., Armstrong, S.C., and Cozza Kelly, L. (2006) Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics. 47, 75-85.
15. Bodor, M., Kelly, E.J., and Ho, R.J. (2005) Characterization of the human MDR1 gene. AAPS J. 07, E1-E5.
16. Southern, E.M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503-517.
17. Wallace, R.B., Shaffer, J., Murphy, R.F., Bonner, J., Hirose, T., and Itakura, K. (1979) Hybridization of synthetic oligodeoxyribonucleotides to phi chi 174 DNA: the effect of single base pair mismatch. Nucleic Acids Res. 6, 3543-3557.
18. Chee, M., Yang, R., Hubbell, E., et al. (1996) Accessing genetic information with high-density DNA arrays. Science. 274, 610-614.
19. Schena, M., Shalon, D., Davis, R.W., and Brown, P.O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270, 467-470.
20. Bowtell, D.D.L. (1999) Options available-from start to finish for obtaining expression data by microarray. Nat. Genet. 21, 25-32.
21. Hardiman, G. (2004) Microarray platforms-comparisons and contrasts. Pharmacogenomics, 5, 487-502.
22. Wick, I., and Hardiman, G. (2005) Biochip platforms as functional genomics tools for drug discovery. Curr. Opin. Drug Discov. Dev. 8, 347-354.
23. Gunderson, K.L., Steemers, F.J., Lee, G., Mendoza, L.G., and Chee, M.S. (2005) A genomewide scalable SNP genotyping assay using microarray technology. Nat. Genet. 37, 549-554.
24. Steemers, F.J., Chang, W., Lee, G., Barker, D.L., Shen, R., and Gunderson, K.L. (2006) Whole-genome genotyping with the single-base extension assay. Nat. Methods. 3, 31-33.
25. Mahant, V., Kureshy, F., Vairavan, R., and Hardiman, G. (2003) The INFINITI system-an automated multiplexing microarray platform, in Microarray Methods and Applications, vol. 16 (G. Hardiman, ed.), DNA Press, Eagleville, PA, pp. 325-328.
26. Kim, P., Fu, Y.K.K., Mahant, V., Kureshy, F., Hardiman, G., and Corbeil, J. (2006) The next generation of automated microarray platform for a multiplexed CYP2D6 assay, in Biochips as Pathways to Discovery, vol. 6 (A. Carmen and G. Hardiman, eds.) Taylor and Francis, New York, pp. 97-108.
27. Gygi, S.P., Rochon, Y., Franza, B., and Abersold, R. (1999) Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 19, 1720-1730.